RWJ-445167

N/A

Report date: 2023/11/30 11:27:47
NME

Base Information

Drug NameRWJ-445167
Drug Alias NameRWJ-4451673DP-10017
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionCoagulation factor X stimulantsThrombin inhibitors
TargetsCoagulation factor XProthrombin
Therapy Area/IndicationsThrombosis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesJohnson & Johnson
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesJohnson & Johnson
Active IndicationsN/A
Inactive IndicationsThrombosis

Other Information

ATC CodeN/A
Related LinksN/A